UPDATE 2-Boston Scientific profit beats as heart stent sales rise

April 27 (Reuters) - Boston Scientific Corp reported

a better-than-expected quarterly profit, boosted by higher sales

of its heart stents and clot-removal product, and the medical

device maker raised its full-year revenue forecast.

Read more